Delivery Order SPE2DB22D2206-SPE2DB24FJF84
Award Date
7/16/24
Potential Completion Date
7/17/24
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $1,161.08 firm fixed price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pen 3 ml, a prescription medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support...
This federal contract award, with a ceiling value of $11,015.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The award is for a delivery order to supply the pharmaceutical product Ozempic (0.25-0.5 mg/dose pen, 3 mL) to the government. It is a firm-fixed-price contract with a period of performance through July 2024. The contract is not designated as a set-aside. AmerisourceBergen, as a major pharmaceutical distributor, has been...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $9,550.87 firm-fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. The award is not under a set-aside program. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. government, holding significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $8,959.79 firm fixed price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. The contract has an ultimate completion date of July 31, 2024. AmerisourceBergen, a large pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025,...
This federal contract award is a delivery order issued to AmerisourceBergen Drug Corp, Corporate Office Division, by the Defense Logistics Agency (DLA) valued at $5,959.91. The award is for the procurement of OZEMPIC 0.25-0.5 MG/DOSE PEN 3ML, a pharmaceutical product. The contract does not have a set-aside designation and has a period of performance through August 1, 2024. AmerisourceBergen, a major pharmaceutical distributor, has multiple indefinite delivery contracts (IDCs) with various...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The $4,508.61 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency. The contract has an ultimate completion date of July 31, 2024 and is not designated as a small business set-aside. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $39,683.30 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens, with a completion date of August 14, 2024. AmerisourceBergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of essential medical products and supplies to military treatment facilities,...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic 0.25-0.5 mg/dose pen 3 ml. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $7,227.80 and an ultimate completion date of August 16, 2024. AmerisourceBergen, through its Corporate Office division, will be responsible for delivering this pharmaceutical product to support federal healthcare programs and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $11,953.02 firm-fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. The award has an ultimate completion date of August 28, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) to provide a wide range of medical commodities, including...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $2,877.34 firm-fixed price delivery order is for the supply of OZEMPIC 0.25-0.5 mg/dose pens. This contract has an ultimate completion date of August 9, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., leverages its extensive supply chain to provide a wide range of medications and medical supplies to various government...